Transcriptional Dysregulation of Upstream Signaling of IFN Pathway in Chronic HCV Type 4 Induced Liver Fibrosis.

Transcriptional Dysregulation of Upstream Signaling of IFN Pathway in Chronic HCV Type 4 Induced Liver Fibrosis.

IFN orchestrates the expression of various genes to halt hepatitis C virus (HCV) replication with the possibility of either reduced or increased liver fibrosis; due to controlled viral replication or overproduction of inflammatory mediators, repectively. In this study, we examined the transcriptiona...

Full description

Bibliographic Details
Main Authors:	Marwa K Ibrahim, Ghada Maher Salum, Noha G Bader El Din, Reham M Dawood, Ahmed Barakat, Ahmed Khairy, Mostafa K El Awady
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2016-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4852926?pdf=render

Similar Items

Correlation between IL28B/TLR4 genetic variants and HCC development with/without DAAs treatment in chronic HCV patients
by: Ghada M. Salum, et al.
Published: (2020-09-01)

A multiepitope peptide vaccine against HCV stimulates neutralizing humoral and persistent cellular responses in mice
by: Reham M. Dawood, et al.
Published: (2019-11-01)

Assessment of human cytomegalovirus co-infection in Egyptian chronic HCV patients
by: Nabil Mohamed, et al.
Published: (2011-07-01)

Genetic distance and heterogenecity between quasispecies is a critical predictor to IFN response in Egyptian patients with HCV genotype-4
by: Fouad Inas, et al.
Published: (2007-02-01)

Circulating viral core and E1 antigen levels as supplemental markers for HCV Chronic hepatitis
by: El Awady Mostafa K, et al.
Published: (2006-09-01)

Bioinformatics prediction of B and T cell epitopes within the spike and nucleocapsid proteins of SARS-CoV2
by: Reham M. Dawood, et al.
Published: (2021-02-01)

Evaluation of seven gene signature for predicting HCV recurrence post-liver transplantation
by: Ghada M. Salum, et al.
Published: (2021-11-01)

Soluble egg antigen of <it>Schistosoma Haematobium </it>induces HCV replication in PBMC from patients with chronic HCV infection
by: Tabll Ashraf A, et al.
Published: (2006-06-01)

Seven gene signature explores the impact of DAAs on the appearance of hepatocellular carcinoma in HCV infected patients
by: Reham M. Dawood, et al.
Published: (2022-08-01)

Polymorphism in Variable Number of Tandem Repeats of Dopamine D4 Gene is a Genetic Risk Factor in Attention Deficit Hyperactive Egyptian Children: Pilot Study
by: Ola Shahin, et al.
Published: (2015-01-01)

Neutralizing activities of caprine antibodies towards conserved regions of the HCV envelope glycoprotein E2
by: El-Shenawy Reem, et al.
Published: (2011-08-01)

Recognition of 7 genes signature (Cirrhosis Risk Score) in the diagnosed non-responders to DAAs therapy by intra-PBMCs nested HCV RNA PCR
by: Al-Shazly Gaber Mohamed Galal, et al.
Published: (2023-08-01)

Expression of Reactive Oxygen Species–Related Transcripts in Egyptian Children With Autism
by: Nagwa A Meguid, et al.
Published: (2017-02-01)

HCV treatment outcome depends on SNPs of IFNL3-Gene polymorphisms (rs12979860) and cirrhotic changes in liver parenchyma
by: Mohamed Darwish Ahmed Abd Alla, et al.
Published: (2023-11-01)

Endogenous IFNγ in chronic HCV genotype 4 patients treated with PEG-IFNα and ribavirin
by: Sadeq, Refat, et al.
Published: (2013)

Effect of eradication of HCV infection by direct-acting antivirals in diabetic HCV-infected patients as regards glycemic control
by: Mohamed Mohei El Badry, et al.
Published: (2020-11-01)

Mechanism of HCV's resistance to IFN-α in cell culture involves expression of functional IFN-α receptor 1
by: Lamaze Christophe, et al.
Published: (2011-07-01)

Pretreatment Predictors of Response to PegIFN-RBV Therapy in Egyptian Patients with HCV Genotype 4.
by: Hanan H Rizk, et al.
Published: (2016-01-01)

Biochemical differences between nano- and normal formulation of tamoxifen and other natural bioactive materials ameliorate breast cancer in experimental rats
by: Afaf Ezzat, et al.
Published: (2021-04-01)

MicroRNA Signatures for circulating CD133-positive cells in hepatocellular carcinoma with HCV infection.
by: Abdel-Rahman N Zekri, et al.
Published: (2018-01-01)

Effect of HCV treatment with DAAs on serum intestinal fatty acid binding protein (I-FABP) as a marker of intestinal permeability in HCV/HIV co-infected patients
by: Hanan Abdelhaleem, et al.
Published: (2023-04-01)

Dysregulation in IFN-γ signaling and response: the barricade to tumor immunotherapy
by: Jiashu Han, et al.
Published: (2023-05-01)

Novel biomarkers assist in detection of liver fibrosis in HCV patients
by: Tamer A. Addissouky, et al.
Published: (2021-11-01)

Circulating microRNAs as predictors of response to sofosbuvir + daclatasvir + ribavirin in in HCV genotype-4 Egyptian patients
by: Noha Anwar Hassuna, et al.
Published: (2022-12-01)

The correlation of genom mutations in HCV-1b with IFN-sensitivity in Hungarian patients
by: Gervain, J, et al.
Published: (2006)

Individual liver plasmacytoid dendritic cells are capable of producing IFNα and multiple additional cytokines during chronic HCV infection.
by: Erin Heather Doyle, et al.
Published: (2019-07-01)

Pre-Existing HCV Variants Resistant to DAAs and Their Sensitivity to PegIFN/RBV in Chinese HCV Genotype 1b Patients.
by: Yu Zhang, et al.
Published: (2016-01-01)

HCV eradication with IFN-based therapy does not completely restore gene expression in PBMCs from HIV/HCV-coinfected patients
by: Óscar Brochado, et al.
Published: (2021-03-01)

SH2 modified STAT1 induces HLA-I expression and improves IFN-γ signaling in IFN-α resistant HCV replicon cells.
by: Bret Poat, et al.
Published: (2010-09-01)

Gene expression profiling of circulating CD133+ cells of hepatocellular carcinoma patients associated with HCV infection
by: Abdel-Rahman N. Zekri, et al.
Published: (2017-03-01)

Transcriptional responses define dysregulated immune activation in Hepatitis C (HCV)-naïve recipients of HCV-infected donor kidneys
by: Julie M. Steinbrink, et al.
Published: (2023-01-01)

Transcriptional responses define dysregulated immune activation in Hepatitis C (HCV)-naïve recipients of HCV-infected donor kidneys.
by: Julie M Steinbrink, et al.
Published: (2023-01-01)

IFN-Alpha receptor-1 upregulation in PBMC from HCV naïve patients carrying cc genotype. possible role of IFN-lambda.
by: Eleonora Lalle, et al.
Published: (2014-01-01)

Injection drug use is a risk factor for HCV infection in urban Egypt.
by: Adela Paez Jimenez, et al.
Published: (2009-01-01)

Correction: SH2 Modified STAT1 Induces HLA-I Expression and Improves IFN-γ Signaling in IFN-α Resistant HCV Replicon Cells.
by: Bret Poat, et al.
Published: (2010-01-01)

Body mass index (BMI) and alpha-fetoprotein (AFP) level correlate with the severity of HCV-induced fibrosis in a cohort of Egyptian patients with chronic HCV
by: Amal Ahmed Mohamed, et al.
Published: (2020-10-01)

Antisense oligonucleotide inhibition of hepatitis C virus genotype 4 replication in HepG2 cells
by: Omran Moataza H, et al.
Published: (2006-06-01)

A phase 2 study of filibuvir in combination with pegylated IFN alfa and ribavirin for chronic HCV
by: Maribel Rodriguez-Torres, et al.
Published: (2014-07-01)

Impact of IFN-Free and IFN-Based Treatment on Blood Myeloid Dendritic Cell, Monocyte, Slan-DC, and Activated T Lymphocyte Dynamics during HCV Infection
by: Serena Vita, et al.
Published: (2020-01-01)

The IFN-γ receptor promotes immune dysregulation and disease in STING gain-of-function mice
by: W. Alexander Stinson, et al.
Published: (2022-09-01)